Orthosera's Series B Round

Orthosera raised a round of funding on February 09, 2017. Investors include Euroventures.

OrthoSera is a commercial-stage regenerative medicine company. The serum-based approach to address various degenerative diseases like osteoarthritis is driving the ambition to become a game changer in…

Articles about Orthosera's Series B Round: